Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters. - Wikidata - wikimedia - TriplyDB

Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters.

Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters.

http://www.wikidata.org/entity/Q33827370

about

Classical and emerging roles of vitamin D in hepatitis C virus infection New Pathogenic Concepts and Therapeutic Approaches to Oxidative Stress in Chronic Kidney Disease Nutrition and Inflammation in Older Individuals: Focus on Vitamin D, n-3 Polyunsaturated Fatty Acids and Whey Proteins Prevalence and prognostic implications of vitamin D deficiency in chronic kidney disease High-dose cholecalciferol reduces parathyroid hormone in patients with early chronic kidney disease: a pilot, randomized, double-blind, placebo-controlled trial.Effect of cholecalciferol supplementation on inflammation and cellular alloimmunity in hemodialysis patients: data from a randomized controlled pilot trial.Vitamin D prohormone in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.Vitamin D deficiency is associated with mortality and adverse vascular access outcomes in patients with end-stage renal disease Associations between serum-intact parathyroid hormone, serum 25-hydroxyvitamin D, oral vitamin D analogs and metabolic syndrome in peritoneal dialysis patients: a multi-center cross-sectional study Correlations of MTHFR 677C>T polymorphism with cardiovascular disease in patients with end-stage renal disease: a meta-analysis.Prevalence of 25-OH vitamin D deficiency in a population of hemodialysis patients and efficacy of an oral ergocalciferol supplementation regimen Mineral bone disease in maintenance hemodialysis patients: Association with morbidity and mortality.A randomized controlled trial of cholecalciferol supplementation in patients on maintenance hemodialysis.Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials.The effects of progressive resistance training combined with a whey-protein drink and vitamin D supplementation on glycaemic control, body composition and cardiometabolic risk factors in older adults with type 2 diabetes: study protocol for a random Long-term cholecalciferol administration in hemodialysis patients: a single-center randomized pilot study.The relationship between ultraviolet light exposure and mortality in dialysis patients Cardiovascular effects of cholecalciferol treatment in dialysis patients--a randomized controlled trial.The effects of omega-3 fatty acid on vitamin D activation in hemodialysis patients: a pilot study Efficacy and safety of a short course of very-high-dose cholecalciferol in hemodialysis.Effect of vitamin D therapy on endothelial function in ischemic heart disease female patients with vitamin D deficiency or insufficiency: A primary report.Glucose Metabolism Effects of Vitamin D in Prediabetes: The VitDmet Randomized Placebo-Controlled Supplementation Study.Efficacy and safety of body weight-adapted oral cholecalciferol substitution in dialysis patients with vitamin D deficiency.Seasonal variations in mortality and clinical indicators in international hemodialysis populations from the MONDO registry Focus on vitamin D, inflammation and type 2 diabetes Vitamin D therapy in chronic kidney disease and end stage renal disease.Vitamin D deficiency in hemodialysis patients.Ergocalciferol treatment does Not improve erythropoietin utilization and hospitalization rate in hemodialysis patients.Vitamin D supplementation in pre-dialysis chronic kidney disease: A systematic review.25-Hydroxyvitamin D response to cholecalciferol supplementation in hemodialysis.Relationship between vitamin D status and left ventricular geometry in a healthy population: results from the Baltimore Longitudinal Study of Aging.Impaired vitamin D metabolism in CKD Vitamin D status and outcomes after renal transplantation.Low 25-hydroxyvitamin D level is independently associated with non-alcoholic fatty liver disease.Calcium absorption response to cholecalciferol supplementation in hemodialysis.Ergocalciferol Supplementation in Hemodialysis Patients With Vitamin D Deficiency: A Randomized Clinical Trial.Effects of cholecalciferol on functional, biochemical, vascular, and quality of life outcomes in hemodialysis patients The link between bone disease and cardiovascular complications in hemodialysis patients.Effects of high-dose cholecalciferol on serum markers of inflammation and immunity in patients with early chronic kidney disease.Vitamin D and the heart.

P2860

Q24561964-C60A4CE2-DB88-48BE-A51C-B99F57F664CE Q26739475-F337FDDF-AC36-4176-A37C-3EF651AC6C6A Q26752590-DE78331D-3386-4636-9E75-8E617EB7F14C Q27022366-B3E1CE4C-1CEE-45D8-B727-F8B1D0405CF7 Q30524139-8F47C3C5-58A5-4ECA-AF45-91EFAC03D825 Q30858288-857DADA0-BB2B-4E36-A1EA-3A0A20963DA2 Q33703957-28A510B0-89EB-4A67-89CD-4F48AB3A2EF3 Q33818722-AAB4F1CC-203F-45E9-BD55-6260AD561335 Q33837711-12145262-1CED-4B30-B687-8B9F781388F3 Q33933333-5EB6D02B-C193-4F7F-A3CC-F35A44A21868 Q33944765-20F12A40-5724-4104-B9B2-0D1C0266AFCC Q34186438-91D105E7-C64A-4EE0-86DA-63D2ACA4C452 Q34229016-70DC8A0B-980D-47D0-9E3B-36072A0932BD Q34497264-0D630BED-6E50-46EB-B2BC-D2A53369E7B6 Q34517931-CB9A26CA-6645-4C68-BE07-081BC4139AB4 Q34548581-3F8BF4C6-C244-4656-A2E1-B3858F78BD7B Q34812456-6587992C-49CF-4234-973E-3C2B3C42AB13 Q35128801-776EBA99-F948-4370-9692-51737D689342 Q35131450-D4F0AA95-9359-4696-9AB9-7AA90998EDFC Q35677318-4A519517-1732-4412-9E1F-B0A987C5746C Q35698588-40941458-F0D5-4A19-9B8A-2EEFFFCB7B8F Q35708527-5C2D129C-0EBC-41CC-9CA3-A47A9E084356 Q35735678-CD8D24F3-C401-46FD-B8EC-3B7D174AAA8F Q35745490-866DFFCA-3EE5-4083-A6B7-A9F662AE4AF2 Q35749555-09F7D024-385B-4F3D-9E89-84922F4075DD Q35758581-288DB035-AA24-4F18-89BF-86F31EFF4571 Q35856083-62AC1FEF-717B-4BFF-A67D-3FB6B7E8FC27 Q36157949-3B2D0338-96FB-49A4-9F6C-3DA74F9AC719 Q36187587-5301E05D-92A5-4EA3-945F-53326DEC1C64 Q36199529-F7AFBA8C-CB6F-465A-B376-CC43B1CDCD52 Q36598665-B6C033B4-2CA4-4AEF-8795-A3F53D536C2B Q36668070-A9D1F176-0E66-42D0-AB7A-64EF8788C865 Q36796584-F8C8783A-C20C-4C70-8E5D-03349DD9399F Q36859567-9C78D61B-F314-4C2C-AC07-D94583642A4F Q36910915-5BFC637D-9692-405F-8B91-8E884F1F9F37 Q36944692-F4A05895-8440-4DB5-8DD3-5B27CDDC76EE Q36980309-1D23876E-8825-46C7-820F-7315E5F4A705 Q37136086-05B81AF4-B737-4759-8760-DC11DFBF19EF Q37300443-43396720-608E-4679-8749-D1717485C3ED Q37342339-927D1CC8-EF9F-4820-8076-FF892DE25532

P2860

Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters.

http://www.wikidata.org/entity/Q33827370

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Cholecalciferol supplementatio ...... cardiac dimension parameters.

@ast

Cholecalciferol supplementatio ...... cardiac dimension parameters.

@en

type

label

Cholecalciferol supplementatio ...... cardiac dimension parameters.

@ast

Cholecalciferol supplementatio ...... cardiac dimension parameters.

@en

prefLabel

Cholecalciferol supplementatio ...... cardiac dimension parameters.

@ast

Cholecalciferol supplementatio ...... cardiac dimension parameters.

@en

P1433

Q33827370-8457F5C2-FAE0-4481-BF9F-EA1FE11A8F49

P1476

Q33827370-FE667322-BDC9-48A1-95DF-4153B66BB15A

P2093

Q33827370-637595A8-535C-4D63-A311-113D02522B4E

Q33827370-6B2AC205-34E5-447E-A0DA-07222B8E6950

Q33827370-8ECF8503-7356-4CDA-A948-987E14DAAAC9

Q33827370-98C72E4D-1C0A-450F-9983-AE353DAE6C97

Q33827370-C58C98A6-3130-4F5F-A532-FCA7C9A37E2D

Q33827370-CD665D78-9CE3-4748-BD28-3712E1ADE048

Q33827370-CE9F5BA1-5E81-4A3A-833E-1708E21D3A6B

Q33827370-E20C3A4B-BF39-464D-A769-417DD09CDA93

Q33827370-FEC90C02-8320-4D31-A05E-32646E96711C

P2860

Q33827370-001CC063-E0D4-4D76-BFC7-55AAD8B2EBF4

Q33827370-03021568-23DD-4049-8C48-90372468175A

Q33827370-03DCFACF-EE8B-4968-9786-3411B68E8858

Q33827370-0471F49B-3FD4-4067-9092-F007D4A50C2A

Q33827370-141BD2E1-0D05-46F6-92AF-946BA9D7B473

Q33827370-19D8878E-E8C6-4C4C-A6BA-BB1116913F86

Q33827370-1DACB973-B2DA-470D-B671-4A70851CB277

Q33827370-20668123-3F93-412C-AD1F-59C2B66020B0

Q33827370-318FC99D-2255-40A8-A535-4BA4487CD5A5

Q33827370-31E0116D-9D8E-4A34-BE5A-FBBF5DD9AA2C

P304

Q33827370-4A848570-6CC6-45F5-9E35-F74BA028C662

P31

Q33827370-CF8E477E-F5F1-4442-85B3-17D9A338D386

P356

Q33827370-76346F95-78D4-446C-8219-0A33356DB627

P433

Q33827370-95C8007C-BF85-4263-9C31-C939151D57FE

P478

Q33827370-4F64F31B-181B-4C85-9227-7D7BFFF71B7B

P577

Q33827370-051467DE-0AEE-4201-8352-82138E5E6C6D

P698

Q33827370-986822F2-3760-4B77-B79D-8729D99920CC

P932

Q33827370-D1819427-F18E-4051-A0FF-EEE455BB7052

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Cholecalciferol supplementatio ...... cardiac dimension parameters.

@en

P2093

Aníbal Ferreira

http://www.w3.org/2001/XMLSchema#string

Carina Ferreira

http://www.w3.org/2001/XMLSchema#string

Cristina Jorge

http://www.w3.org/2001/XMLSchema#string

Célia Gil

http://www.w3.org/2001/XMLSchema#string

Inês Aires

http://www.w3.org/2001/XMLSchema#string

José Cortez

http://www.w3.org/2001/XMLSchema#string

Marília Borges

http://www.w3.org/2001/XMLSchema#string

Patrícia João Matias

http://www.w3.org/2001/XMLSchema#string

Tiago Amaral

http://www.w3.org/2001/XMLSchema#string

P2860

Vitamin D and the elderly

Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D

What's new in vitamin D for the nephrologist?

Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis.

1alpha-Hydroxylase and the action of vitamin D.

Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxy-cholecalciferol in uremic patients.

Electrolyte quintet: Calcium.

KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure.

P304

905-911

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.06510909

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20203163

http://www.w3.org/2001/XMLSchema#string

P932

2863968

http://www.w3.org/2001/XMLSchema#string